StockData
Xencor Inc logo

Xencor Inc (XNCR) income statement

XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30188% above fair value
$33.26−0.75 (-2.21%)

Close on Nov 20, 2026Market cap $2.47BP/E –Yield –

Xencor Inc income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
-205.8%
Net margin
-155.6%
Return on equity, FY2025
-14.0%

Financial strength

Current ratio
6.39
Debt to equity
0.21
Debt to assets
14.5%
Cash to current liabilities
54.6%

Valuation

P/E ratio
–
Price to sales
23.56
Price to book
4.91
Dividend yield
–

See a number that looks wrong?